These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12657277)

  • 21. Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine.
    Lin MC; Wang EJ; Lee C; Chin KT; Liu D; Chiu JF; Kung HF
    J Nutr; 2002 Jun; 132(6):1165-8. PubMed ID: 12042427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and pharmacological screening of β-amino-, thiadiazole/thiadiazine-phosphonate based triazole motifs as antimicrobial/cytotoxic agents.
    Abdou WM; Ganoub NA; Sabry E
    Acta Pharm; 2014 Sep; 64(3):267-84. PubMed ID: 25296674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-halo [(phenylphosphinyl)methyl]phosphonates as specific inhibitors of Na(+)-gradient-dependent Na(+)-phosphate cotransport across renal brush border membrane.
    McKenna CE; Pham PT; Rassier ME; Dousa TP
    J Med Chem; 1992 Dec; 35(26):4885-92. PubMed ID: 1479588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 3. Discovery of a novel series of N-alkyl-N-[(fluorophenoxy)benzyl]-N'-arylureas with weak toxicological effects on adrenal glands.
    Tanaka A; Terasawa T; Hagihara H; Ishibe N; Sawada M; Sakuma Y; Hashimoto M; Takasugi H; Tanaka H
    J Med Chem; 1998 Oct; 41(22):4408-20. PubMed ID: 9784116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ezetimibe analogs with a reorganized azetidinone ring: Design, synthesis, and evaluation of cholesterol absorption inhibitions.
    Xu X; Fu R; Chen J; Chen S; Bai X
    Bioorg Med Chem Lett; 2007 Jan; 17(1):101-4. PubMed ID: 17049851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist.
    Bakillah A; Nayak N; Saxena U; Medford RM; Hussain MM
    Biochemistry; 2000 Apr; 39(16):4892-9. PubMed ID: 10769147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion.
    Shiomi M; Ito T
    Eur J Pharmacol; 2001 Nov; 431(1):127-31. PubMed ID: 11716851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells.
    Funatsu T; Suzuki K; Goto M; Arai Y; Kakuta H; Tanaka H; Yasuda S; Ida M; Nishijima S; Miyata K
    Atherosclerosis; 2001 Jul; 157(1):107-15. PubMed ID: 11427209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol lowering bile acid binding agents: novel lipophilic polyamines.
    Thomas EW; Cudahy MM; Spilman CH; Dinh DM; Watkins TL; Vidmar TJ
    J Med Chem; 1992 Apr; 35(7):1233-45. PubMed ID: 1560437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
    Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
    J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells.
    Jamil H; Gordon DA; Eustice DC; Brooks CM; Dickson JK; Chen Y; Ricci B; Chu CH; Harrity TW; Ciosek CP; Biller SA; Gregg RE; Wetterau JR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11991-5. PubMed ID: 8876250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
    Lettéron P; Sutton A; Mansouri A; Fromenty B; Pessayre D
    Hepatology; 2003 Jul; 38(1):133-40. PubMed ID: 12829995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic microsomal triglyceride transfer protein messenger RNA concentrations are increased by dietary cholesterol in hamsters.
    Bennett AJ; Bruce JS; Salter AM; White DA; Billett MA
    FEBS Lett; 1996 Oct; 394(3):247-50. PubMed ID: 8830652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of cultured hamster hepatocytes as an experimental model for the study of very low density lipoprotein secretion.
    Hoang VQ; Pearce NJ; Suckling KE; Botham KM
    Biochim Biophys Acta; 1995 Jan; 1254(1):37-44. PubMed ID: 7811744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
    Tremont SJ; Lee LF; Huang HC; Keller BT; Banerjee SC; Both SR; Carpenter AJ; Wang CC; Garland DJ; Huang W; Jones C; Koeller KJ; Kolodziej SA; Li J; Manning RE; Mahoney MW; Miller RE; Mischke DA; Rath NP; Fletcher T; Reinhard EJ; Tollefson MB; Vernier WF; Wagner GM; Rapp SR; Beaudry J; Glenn K; Regina K; Schuh JR; Smith ME; Trivedi JS; Reitz DB
    J Med Chem; 2005 Sep; 48(18):5837-52. PubMed ID: 16134950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel nucleotide phosphonate analogues with potent antitumor activity.
    Bubenik M; Rej R; Nguyen-Ba N; Attardo G; Ouellet F; Chan L
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3063-6. PubMed ID: 12372502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA: cholesterol O-acyltransferase.
    Ohishi K; Aiyama R; Hatano H; Yoshida Y; Wada Y; Yokoi W; Sawada H; Watanabe T; Yokokura T
    Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):830-9. PubMed ID: 11456087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.